What Has Been the Growth of the Salivary Gland Infection Market So Far?
The salivary gland infection market has seen considerable growth due to a variety of factors.
• The market for salivary gland infection has seen robust growth in the past few years. The market is predicted to expand from $4.12 billion in 2024 to $4.46 billion in 2025, growing at a compounded annual growth rate (CAGR) of 8.4%.
This substantial growth during the historic period is linked to an increase in oral health problems, heightened awareness of salivary diseases, increased prevalence of bacterial and viral infections, expansion of the healthcare infrastructure, a growing elderly population, and an increase in the uptake of minimally invasive therapies.
What Is the Forecasted Market Size and Growth Rate for The Salivary Gland Infection Market Size In The Coming Years?
The salivary gland infection market is expected to maintain its strong growth trajectory in upcoming years.
• Expectations are high for the salivary gland infection market as it is anticipated to exhibit significant growth in the upcoming years. By 2029, it is projected to reach a value of $6.09 billion, boasting a compound annual growth rate (CAGR) of 8.1%.
Several factors contribute to this projection including an increasing awareness for oral health, the growing preference for minimally invasive medical procedures, a rise in chronic health conditions, improvements in health infrastructure, and more accessibility to specialized care for patients. Key trends to look out for during the forecast period are the growing utilization of minimally invasive procedures, enhancements in sialendoscopy techniques, advancements in imaging technologies, development of biocompatible stents, the rise of robotic-assisted surgical procedures, targeted antimicrobial therapies, and the use of AI in diagnostics.
What Factors Are Driving Growth In The Salivary Gland Infection Market?
The escalation in problems linked to oral health is anticipated to propel the progression of the salivary gland infections market in the future. Conditions such as tooth decay, gum disease, and various other issues related to the mouth contribute to oral health problems. Factors such as inadequate oral cleanliness, unhealthy dietary practices, and limited access to dental care are contributing to the increase in oral health concerns. A spike in these concerns enhances the probability of salivary gland infections by nurturing bacterial development and clogging the salivary ducts. For example, in May 2024, the National Health Service (NHS), a government agency in the UK, reported that they provided 32.5 million dental treatments in 2022-23, marking a 23.2% rise versus the preceding year. Consequently, the escalation in oral health problems is a key driver behind the growth in the salivary gland infections market.
What Are The Main Segments Of The Global Salivary Gland Infection Market?
The salivary gland infection market covered in this report is segmented –
1) By Diagnosis: Plain Radiography, Sialography, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Radionuclide Scintigraphy, High-resolution Ultrasonography, Other Diagnoses
2) By Treatment: Medications, Surgery, Aspiration, Home Care, Other Treatments
3) By End User: Hospitals And Clinics, Medical Research Centers, Academic Institutes, Other End User
Subsegments:
1) By Plain Radiography: X-ray Of Salivary Glands, Sialography With X-ray
2) By Sialography: Conventional Sialography, Digital Subtraction Sialography (DSS)
3) By Computed Tomography (CT): Non-contrast CT, Contrast-enhanced CT
4) By Magnetic Resonance Imaging (MRI): MRI without contrast, MRI With contrast (Dynamic MRI)
5) By Radionuclide Scintigraphy: Planar Scintigraphy, SPECT (Single Photon Emission Computed Tomography)
6) By High-resolution Ultrasonography: Standard Ultrasonography, Doppler Ultrasonography
7) By Other Diagnoses: Fine Needle Aspiration (FNA) Biopsy, Endoscopy, Salivary Flow Test
Pre-Book The Salivary Gland Infection Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are Emerging Trends Reshaping The Dynamics Of The Salivary Gland Infection Market?
Key players in the salivary gland infections market are focusing on technological innovations, specifically in procedures that are minimally invasive, to optimize treatment results, quicken patient recuperation, and boost overall healthcare competence. These procedures, characterized by smaller incisions and specialized instruments, result in less damage to the tissue and subsequently faster recovery. For example, in March 2024, Amrita Hospital, a healthcare establishment based in India, unveiled the Amrita Centre for minimally invasive salivary gland surgery. This center provides a revolutionary therapy for salivary disorders using sialendoscopy, which reduces the need for surgery and maintains gland functionality. The inauguration was underscored by a two-day seminar featuring professional demonstrations.
Who Are the Key Players In The Salivary Gland Infection Market?
Major companies operating in the salivary gland infection market are:
• Pfizer Inc.
• Johnson & Johnson
• Roche Holding AG
• Merck & Co. Inc.
• AbbVie Inc.
• AstraZeneca plc
• Novartis AG
• GSK plc
• Eli Lilly and Company
• Gilead Sciences. Inc.
• Amgen Inc.
• FUJIFILM Holdings Corporation
• Teva Pharmaceutical Industries Ltd.
• Boehringer Ingelheim GmbH
• Astellas Pharma Inc.
• Sandoz International GmbH
• Vertex Pharmaceuticals Incorporated. Incyte Corporation.
• Hikma Pharmaceuticals PLC
• Lupin Pharmaceuticals Inc.
• Ionis Pharmaceuticals Inc.
• Vanda Pharmaceuticals Inc.
• Mylan N.V.
• Zydus Cadila Healthcare Ltd.
What Is The Most Dominant Region In The Salivary Gland Infection Market?
North America was the largest region in the salivary gland infection market in 2024. The regions covered in the salivary gland infection market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
